Table 4.
Resistance phenotypes | Enterobacter spp (n = 48) | Escherichia coli (n = 34) | Klebsiella pneumoniae (n = 13) | Klebsiella oxytoca (n = 10) | Total (N = 105) | |||||
---|---|---|---|---|---|---|---|---|---|---|
Non-ESBL isolates (n = 70) | ||||||||||
. | . | . | . | . | . | 24 | 12 | 7 | 7 | 50 |
F | . | . | . | . | . | 15 | 0 | 1 | 0 | 16 |
F | S | . | . | . | . | 0 | 1 | 0 | 0 | 1 |
. | S | . | G | T | C | 0 | 1 | 0 | 0 | 1 |
. | S | . | G | . | C | 0 | 1 | 0 | 0 | 1 |
. | S | . | . | . | . | 0 | 0 | 1 | 0 | 1 |
ESBL isolates (n = 35) | ||||||||||
. | S | . | G | T | C | 5 | 7 | 0 | 0 | 12 |
. | S | A | G | T | C | 3 | 0 | 0 | 0 | 3 |
. | . | . | . | T | C | 0 | 3 | 0 | 0 | 3 |
. | . | . | . | . | C | 0 | 3 | 0 | 0 | 3 |
F | S | A | G | T | C | 0 | 1 | 1 | 0 | 2 |
. | S | . | G | T | . | 0 | 0 | 2 | 0 | 2 |
. | S | . | . | T | C | 0 | 2 | 0 | 0 | 2 |
. | S | . | . | . | . | 1 | 0 | 0 | 1 | 2 |
F | S | . | G | T | C | 0 | 1 | 0 | 0 | 1 |
F | . | . | G | T | C | 0 | 0 | 1 | 0 | 1 |
F | . | . | . | . | C | 0 | 0 | 0 | 1 | 1 |
. | S | A | . | T | C | 0 | 1 | 0 | 0 | 1 |
. | . | . | G | T | C | 0 | 0 | 0 | 1 | 1 |
. | . | . | G | . | C | 0 | 1 | 0 | 0 | 1 |
A, amikacin resistant; C, ciprofloxacin resistant; ESBL, extended-spectrum β-lactamase; F, cefoxitin resistant; G, gentamicin resistant; S, sulfamethoxazole-trimethoprim resistant; T, tobramycin resistant;., susceptible.